Alternating radiotherapy and chemotherapy for inoperable stage III non- small-cell lung cancer: Long-term results of two phase II GOTHA trials

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 3, 1998, Pages 487-494

  Mirimanoff, René Olivier ^a   Moro, Denis ^b   Bolla, Michel ^b   Michel, Geneviève ^b   Brambilla, Christian ^b   Mermillod, Bernadette ^b   Miralbell, Raymond ^b   Alberto, Pierre ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NONE

Author keywords

Chemotherapy; Combined modality; Inoperable lung cancer; Non small cell lung cancer; Radiotherapy

Indexed keywords

CISPLATIN; MITOMYCIN; VINDESINE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DYSPNEA; FEMALE; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; SECOND CANCER; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOMYCINS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; SURVIVAL RATE; VINDESINE;

EID: 0031755665     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00246-6     Document Type: Article

References (52)

1. Van Houtte P, Gregor A, Phillips P. International survey of radiotherapy practice for radical treatment of non-small cell lung cancer. Lung Cancer 1994;11(Suppl. 3):129-138.
2. Choi NC, Doucette JA. Improved survival of patients with unresectable non-small cell bronchogenic carcinoma by an innovative high dose en-bloc radiotherapeutic approach. Cancer 1981;48:101-109.
3. Perez CA, Pajak TF, Rubin P, et al. long-term observation of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy: Report by the Radiation Therapy Oncology Group. Cancer 1987;59:1874-1881.
4. Green MR. The role of induction chemotherapy before radiation therapy in non-operative management of stage III NSCLC. Lung Cancer 1994;11(Suppl 3):55-65.
5. Komaki R. Combined chemotherapy and radiation therapy in surgically unresectable regionally advanced non-small cell lung cancer. Semin Radiat Oncol 1996;6:86-91.
6. Mirimanoff RO. Concurrent chemotherapy and radiotherapy in locally advanced non-small cell lung cancer: A review. Lung Cancer 1994;11(Suppl. 3):79-99.
7. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small cell lung cancer: Seven year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 1996;88:1210-1215.
8. Jeremic B, Shibamoto Y, Acimovic L, et al. Randomized trial of hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III non-small cell lung cancer. J Clin Oncol 1995;13:452-458.
9. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in non resectable non-small cell lung carcinoma. J Natl Cancer Inst 1991;83:417-423.
10. Le Chevalier G, Arriagada R, Tarayre M, et al. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma [letter]. J Natl Cancer Inst 1992;84:58.
11. Sause WT, Scott C, Taylor S, et al. Radiation Oncology Therapy Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 1995;87:198-205.
12. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effect of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992;326:524-530.
13. Alberto P, Mirimanoff RO, Mermillod B, et al. Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: Results of a phase I-II study by the GOTHA group. Eur J Cancer 1995;31A:342-348.
14. Goldie JH, Coldman AJ. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-1733.
15. Looney WB, Goldie JH, Little JB, et al. Alternation of chemotherapy and radiotherapy in cancer management. Cancer Treat Rep 1985;69:769-775.
16. WHO Handbook for reporting results of cancer treatment. Geneva: WHO; 1979.
17. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assos 1958;53:457-481.
18. Dorey FJ, Korn EL. Effective sample size for confidence intervals for survival probabilities. Stat Med 1987;6:679-687.
19. Rothman KJ. Simulation of confidence limits for the cumulative probability of survival in life table analysis. J Chron Dis 1978;31:557-560.
20. Efron B. Censored data and the bootstrap. J Am Stat Assos 1981;76:312-319.
21. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
22. Cox JD, Byhardt RW, Komaki R. The role of radiotherapy in squamous, large cell, and adenocarcinoma of the lung. Semin Oncol 1983;10:81-94.
23. Sause WT. Combination chemotherapy and radiation therapy in lung cancer. Semin Oncol 1994;21(S6):72-78.
24. Van Houtte P. Induction or concomitant chemotherapy and radiotherapy for non-small cell lung cancer: Myth or reality? Ann Oncol 1995;6(Suppl. 3):37-40.
25. Japan Radiation-ACNU Study Group. A randomized prospective study of radiation versus radiation plus ACNU in inoperable non-small cell carcinoma of the lung. Cancer 1985;63:249-254.
26. Johnson DH, Einhorn LH, Bartolucci A, et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 1990;113:33-38.
27. Morton RF, Jett JR, McGinnis WL, et al. Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non-small cell lung cancer. Ann Intern Med 1991;115:681-686.
28. Schallier DC, De Neve WJ, De Greve JL, et al. Is adjuvant treatment with vinblastine effective in reducing the occurrence of distant metastasis in limited squamous-cell lung cancer? A randomized study. Clin Exp Metastasis 1988;6:39-48.
29. Blanke C, Ansari R, Mantravadi R, et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: A Hoosier Oncology Group protocol. J Clin Oncol 1995;13:1425-1429.
30. Mattsen K, Holsti LR, Holsti P, et al. Inoperable non-small cell lung cancer: Radiation with or without chemotherapy. Eur J Clin Oncol 1988;24:477-482.
31. Soresi E, Clerici M, Grilli R, et al. A randomized clinical trial comparing radiation vs. radiation therapy plus cis-dichlorodiammine platinum in the treatment of locally advanced non-small cell lung cancer. Semin Oncol 1988;15:20-25.
32. Trovo MG, Minatel E, Veronesi A, et al. Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma (a randomised study). Cancer 1990;65:400-404.
33. Van Houtte P, Klasterski J, Renaud A, et al. Induction chemotherapy with cisplatin, etoposide and vindesin before radiation therapy for non-small cell lung cancer. Antibiot Chemother 1988;41:131-137.
34. Anonymous. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995;311:899-909.
35. Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stage IIIa and IIIb non-small cell lung cancer: A meta-analysis. Cancer 1995;76:593-601.
36. Lee JS, Scott C, Komaki R, et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer: Radiation Therapy Oncology Group protocol 91-06. J Clin Oncol 1996;14:1055-1064.
37. Le Péchoux C, Arriagada R, Le Chevalier T, et al. Concurrent cisplatin-vindesin and hyperfractionated thoracic radiotherapy in locally advanced non-small cell lung cancer, Int J Radiat Oncol Biol Phys 1996;35:519-525.
38. Reboul F, Brewer Y, Vincent P, et al. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III non-small cell lung cancer: A phase II study, Int J Radiat Oncol Biol Phys 1996;35:343-350.
39. Shaw E, McGinnis WL, Jett JR, et al. Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomittant etoposide and cisplatin chemotherapy in patients, with unresectable stage III non-small cell carcinoma of the lung. J Natl Cancer Inst 1993;85:321-323.
40. Arriagada R, Le Chevalier T, Quoix E, et al. ASTRO plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients, Int J Radiat Oncol Biol Phys 1991;20:1183-1190.
41. Byhardt RW, Cott CB, Ettinger BS, et al. Concurrent hyperfractionated irradiation and chemotherapy for unresectable non-small cell lung cancer: Results of Radiation Therapy Oncology Group 90-15. Cancer 1995;75:2337-2344.
42. Furuse K, Kubota K, Kawahara M, et al. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small cell lung cancer. J Clin Oncol 1995;13:869-875.
43. Hazuka MB, Crowley JJ, Bunn PA, et al. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small cell cancer: Results of a phase II Southwest Oncology Group Study. J Clin Oncol 1994;12:1814-1820.
44. Pisch J, Berson AM, Molamud S, et al. Chemoradiation in advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1995;33:183-188.
45. Armstrong JG, Zelefsky MJ, Leibel SH, et al. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol 1995;6:693-697.
46. Graham MV, Jain NL, Kaha MJ, et al. Evaluation of an objective plan evaluation model in the three dimensional treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1996;34:469-474.
47. Hazuka M, Turrisi AT III, Lutz ST, et al. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: A retrospective multivariate analysis. Int J Radiat Oncol Biol Phys 1993;27:273-284.
48. Sibley GS, Mundt HJ, Shapiro C, et al. The treatment of stage III non-small cell lung cancer using high dose conformal radiotherapy. Int J Radiat Oncol Biol Phys 1995;33:1001-1007.
49. 2 (clinical) non-small cell carcinoma of the lung: Prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1991;20:7-12.
50. Saunders MI, Dische S, Barrett A, et al. Randomised multi-centre trials of CHART vs conventional radiotherapy in head and neck and non-small cell lung cancer: An interim report. Br J Cancer 1996;73:1455-1462.
51. McDonald S, Chang AY, Rubin P, et al. Combined betaseron R (Recombinant Human Interferon Beta) and radiation for inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993;27:613-619.
52. Bonomi P. Chemotheray for Stage IV non-small cell lung cancer: Protocol versus non-protocol? Is non investigational treatment worthwhile? Patient selection? Which regimen? What's next? Semin Radiat Oncol 1996;6:110-117.